Literature DB >> 25468910

Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.

Matthew D Ward1, Daniel J Leahy2.   

Abstract

The EGF receptor (EGFR) family comprises four homologs in humans collectively known as the ErbB or HER proteins. ErbB proteins are receptor tyrosine kinases that become activated when ligands bind to their extracellular regions and promote formation of specific homo- and heterodimers with enhanced tyrosine kinase activity. An essential feature of ErbB activation is formation of an asymmetric kinase dimer in which the C-terminal lobe of one kinase serves as the activator or donor kinase by binding the N-terminal lobe of a receiver or acceptor kinase and stabilizing its active conformation. ErbB extracellular regions are also thought to form active asymmetric dimers in which only one subunit binds ligand. The observation that the unliganded ErbB2 kinase preferentially serves as the activator kinase when paired with EGFR/ErbB1 implied that extracellular asymmetry in ErbB proteins might be coupled to intracellular asymmetry with unliganded partners favoring the activator kinase position. Using cell-based stimulation assays and chimeric ErbB proteins, we show that extracellular asymmetry is not coupled to intracellular asymmetry and that ErbB intracellular regions are sufficient to determine relative kinase activator-receiver orientation. We further show a hierarchy of activator-receiver preferences among ErbB proteins, with EGFR/ErbB1 being the strongest receiver, followed by ErbB2 and then ErbB4, and that cis-phosphorylation of EGFR and ErbB2 appears to be negligible. This hierarchy shapes the nature of signaling responses to different ligands in cells expressing multiple ErbB proteins.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cell-surface Receptor; Epidermal Growth Factor (EGF); Epidermal Growth Factor Receptor (EGFR); Phosphotyrosine signaling; Receptor Tyrosine Kinase

Mesh:

Substances:

Year:  2014        PMID: 25468910      PMCID: PMC4340403          DOI: 10.1074/jbc.M114.612085

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.

Authors:  Samuel Bouyain; Patti A Longo; Shiqing Li; Kathryn M Ferguson; Daniel J Leahy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

4.  Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation.

Authors:  R Lammers; E Van Obberghen; R Ballotti; J Schlessinger; A Ullrich
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

Review 5.  Specificity within the EGF family/ErbB receptor family signaling network.

Authors:  D J Riese; D F Stern
Journal:  Bioessays       Date:  1998-01       Impact factor: 4.345

6.  Mechanism for activation of mutated epidermal growth factor receptors in lung cancer.

Authors:  Monica Red Brewer; Cai-Hong Yun; Darson Lai; Mark A Lemmon; Michael J Eck; William Pao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

7.  The cellular response to neuregulins is governed by complex interactions of the erbB receptor family.

Authors:  D J Riese; T M van Raaij; G D Plowman; G C Andrews; D F Stern
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.

Authors:  Chafen Lu; Li-Zhi Mi; Michael J Grey; Jieqing Zhu; Elizabeth Graef; Shigeyuki Yokoyama; Timothy A Springer
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

Review 9.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

10.  A new bioinformatics analysis tools framework at EMBL-EBI.

Authors:  Mickael Goujon; Hamish McWilliam; Weizhong Li; Franck Valentin; Silvano Squizzato; Juri Paern; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2010-05-03       Impact factor: 16.971

View more
  12 in total

Review 1.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

2.  Endothelial ErbB4 deficit induces alterations in exploratory behavior and brain energy metabolism in mice.

Authors:  Gang Wu; Xiu-Xiu Liu; Nan-Nan Lu; Qi-Bing Liu; Yun Tian; Wei-Feng Ye; Guo-Jun Jiang; Rong-Rong Tao; Feng Han; Ying-Mei Lu
Journal:  CNS Neurosci Ther       Date:  2017-04-18       Impact factor: 5.243

3.  Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation.

Authors:  Melody D Fulton; Laura E Hanold; Zheng Ruan; Sneha Patel; Aaron M Beedle; Natarajan Kannan; Eileen J Kennedy
Journal:  Bioorg Med Chem       Date:  2017-09-05       Impact factor: 3.641

4.  Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.

Authors:  Kanika Bajaj Pahuja; Thong T Nguyen; Bijay S Jaiswal; Kumar Prabhash; Tarjani M Thaker; Kate Senger; Subhra Chaudhuri; Noelyn M Kljavin; Aju Antony; Sameer Phalke; Prasanna Kumar; Marco Mravic; Eric W Stawiski; Derek Vargas; Steffen Durinck; Ravi Gupta; Arati Khanna-Gupta; Sally E Trabucco; Ethan S Sokol; Ryan J Hartmaier; Ashish Singh; Anuradha Chougule; Vaishakhi Trivedi; Amit Dutt; Vijay Patil; Amit Joshi; Vanita Noronha; James Ziai; Sripad D Banavali; Vedam Ramprasad; William F DeGrado; Raphael Bueno; Natalia Jura; Somasekar Seshagiri
Journal:  Cancer Cell       Date:  2018-10-25       Impact factor: 31.743

5.  Molecular dynamics simulations of asymmetric heterodimers of HER1/HER2 complexes.

Authors:  Chonticha Suwattanasophon; Napat Songtawee; Peter Wolschann; Kiattawee Choowongkomon
Journal:  J Mol Model       Date:  2017-12-26       Impact factor: 1.810

6.  Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor Receptor.

Authors:  Erika Kovacs; Rahul Das; Qi Wang; Timothy S Collier; Aaron Cantor; Yongjian Huang; Kathryn Wong; Amar Mirza; Tiago Barros; Patricia Grob; Natalia Jura; Ron Bose; John Kuriyan
Journal:  Mol Cell Biol       Date:  2015-06-29       Impact factor: 4.272

7.  Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation - molecular dynamics study.

Authors:  Zahra Motamedi; Hassan Rajabi-Maham; Maryam Azimzadeh Irani
Journal:  J Mol Model       Date:  2021-11-24       Impact factor: 1.810

8.  Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling.

Authors:  Avafia Y Dossa; Oswaldo Escobar; Jamie Golden; Mark R Frey; Henri R Ford; Christopher P Gayer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-25       Impact factor: 4.052

9.  Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics.

Authors:  Anatoly Kiyatkin; Iris K van Alderwerelt van Rosenburgh; Daryl E Klein; Mark A Lemmon
Journal:  Sci Signal       Date:  2020-08-18       Impact factor: 8.192

Review 10.  Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia.

Authors:  Laurel E Black; Jody F Longo; Steven L Carroll
Journal:  Am J Pathol       Date:  2019-07-25       Impact factor: 5.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.